SynthesisMedicine2016

The efficacy and safety of platinum plus gemcitabine (PG) chemotherapy with or without molecular targeted agent (MTA) in first-line treatment of non-small cell lung cancer (NSCLC).

Jiaying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.